San Diego, CA, November 16, 2022 — Objective, Investment Banking & Valuation, a leading middle market investment banking and valuation firm, is pleased to announce that its Valuation Advisory Services practice served as the fairness opinion provider to the Board of Directors of Ra Medical Systems, Inc. (NYSE American: RMED) in connection with its proposed merger with Catheter Precision, Inc.
About Objective, Investment Banking & Valuation
Objective, Investment Banking & Valuation is an award-winning valuation and investment banking firm serving middle market companies. Our Valuation Advisory Services practice specializes in providing financial reporting, transaction opinions, tax advisory, and strategic advisory services across all industries. The Valuation Advisory Services practice has been recognized many times for its commitment to excellence including Valuation Firm of The Year 2022 & 2021 by the M&A Advisor, Top 10 Valuation Services Firms in US 2021 by CIO Bulletin, and many more. For more information, visit objectiveibv.com.
—
For Immediate Inquiries:
Channing Hamlet
Managing Director, Investment Banking
(310) 570‑2721
Disclosure
The above testimonials may not be representative of the experience of other customers and is not a guarantee of future performance or success.
This news release is for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC make no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person. Securities and investment banking services are offered through BA Securities, LLC Member FINRA, SIPC. Principals of Objective Capital are Registered Representatives of BA Securities. Objective Capital Partners and BA Securities are separate and unaffiliated entities.
[/vc_column_text][/vc_column][/vc_row]
